Clinical trials
Active, not recruiting Phase 2 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
189 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 12 |
| 2016 | 16 |
| 2017 | 12 |
| 2018 | 12 |
| 2019 | 19 |
| 2020 | 20 |
| 2021 | 21 |
| 2022 | 18 |
| 2023 | 16 |
| 2024 | 14 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 189 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 11 |
| Dana-Farber Cancer Institute | 10 |
| City of Hope Medical Center | 8 |
| M.D. Anderson Cancer Center | 8 |
| MedSIR | 6 |
| National Cancer Institute (NCI) | 6 |
| Pfizer | 5 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 5 |
| Borstkanker Onderzoek Groep | 3 |
| Hoffmann-La Roche | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 189 |
| Triple Negative Breast Neoplasms | 19 |
| Colorectal Neoplasms | 8 |
| Neoplasm Metastasis | 6 |
| Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Pancreatic Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Carcinoma, Intraductal, Noninfiltrating | 4 |
| Carcinoma, Lobular | 4 |
Trials
Showing 1 to 25 of 189. Each trial links to its page on Pharma Observatory.
89 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.